Avery Carter
Cardiovascular Disease · Weston, FLNPI 1114414489
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $733, 3.1 times the $236 reported in 2021. That places this record below the midpoint for cardiovascular disease clinicians in FL, where the typical reported total is $2,774.
Across 61 payments — averaging $41.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$378
- Abbott$364
- E.r. Squibb & Sons, L.L.C.$329
- Medtronic$263
- AstraZeneca$222
- Novartis$189
- plus $792 from 16 others
What the payments were for
- Food & beverage$2,538100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 8 | $378 |
| Abbott | 6 | $364 |
| E.r. Squibb & Sons, L.L.C. | 8 | $329 |
| Medtronic | 8 | $263 |
| AstraZeneca | 3 | $222 |
| Novartis | 8 | $189 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $133 |
| AbbVie | 1 | $125 |
| Insmed, Inc. | 1 | $119 |
| GSK | 1 | $118 |
| Merck | 2 | $53 |
| Amgen | 2 | $37 |
| Boston Scientific | 1 | $30 |
| Terumo Medical Corporation | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $22 |
| Baxter Healthcare | 1 | $22 |
| Pfizer | 1 | $22 |
| Cardiva Medical, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $17 |
| Bayer | 1 | $16 |
| Teleflex LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$213
- CARDIOMEMS$154
- DRAGONFLY OPSTAR$142
- Impella$138
- COREVALVE EVOLUT R$132
- EMBLAVEO$125
- NUCALA$118
How this compares
$2,538 in reported general payments places this provider in the 45th percentile of 1,740 cardiovascular disease providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 34 | $577 |
| Ranolazine ErRanolazine | 16 | $471 |
| ClopidogrelClopidogrel Bisulfate | 20 | $441 |
| Losartan Potassium | 14 | $389 |
| Spironolactone | 22 | $259 |
| Atorvastatin Calcium | 19 | $219 |
| Ezetimibe | 16 | $217 |
| Carvedilol | 16 | $212 |
| Metoprolol Tartrate | 19 | $96 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Weston
- David WolinskyWeston$390K
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
- Seth BaumBoca Raton$517K
- Elliott EliasMiami$497K
- Vijay HaryaniVero Beach$413K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.